Astellas Pharma Inc.

Rachunek Zysków i Strat


Profil spółki
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 1 701 805
EBIT TTM (mln): 36 584
index 0 1 2 3 4 5 6 7 8 9 10 11
Rok finansowy 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 1,005,612 1,139,909 1,247,259 1,372,706 1,311,665 1,300,316 1,306,348 1,300,843 1,249,528 1,296,163 1,518,619 1,603,672
Przychód Δ r/r 0.0% 13.4% 9.4% 10.1% -4.4% -0.9% 0.5% -0.4% -3.9% 3.7% 17.2% 5.6%
Marża brutto 67.8% 71.0% 73.3% 72.5% 72.8% 74.6% 74.9% 77.1% 78.4% 78.3% 78.5% 75.6%
EBIT (mln) 153,867 183,094 226,873 270,577 276,419 271,241 280,141 279,419 250,897 220,021 285,430 178,070
EBIT Δ r/r 0.0% 19.0% 23.9% 19.3% 2.2% -1.9% 3.3% -0.3% -10.2% -12.3% 29.7% -37.6%
EBIT (%) 15.3% 16.1% 18.2% 19.7% 21.1% 20.9% 21.4% 21.5% 20.1% 17.0% 18.8% 11.1%
Koszty finansowe (mln) 0 0 0 1,257 1,334 1,309 1,302 3,004 2,335 4,949 3,620 12,005
EBITDA (mln) 211,723 247,398 292,347 339,765 340,210 336,104 343,599 345,815 323,549 299,705 391,168 335,910
EBITDA(%) 21.1% 21.7% 23.4% 24.8% 25.9% 25.8% 26.3% 26.6% 25.9% 23.1% 25.8% 20.9%
Podatek (mln) 41,822 31,100 53,827 68,083 63,069 53,434 26,702 49,939 24,734 32,800 33,647 7,924
Zysk Netto (mln) 82,851 90,874 135,856 193,687 218,701 164,679 222,265 195,411 120,589 124,086 98,714 17,045
Zysk netto Δ r/r 0.0% 9.7% 49.5% 42.6% 12.9% -24.7% 35.0% -12.1% -38.3% 2.9% -20.4% -82.7%
Zysk netto (%) 8.2% 8.0% 10.9% 14.1% 16.7% 12.7% 17.0% 15.0% 9.7% 9.6% 6.5% 1.1%
EPS 36.03 40.39 61.4 89.62 103.55 81.11 115.05 104.15 64.93 67.08 54.24 9.5
EPS (rozwodnione) 36.03 40.39 61.4 89.62 103.55 81.02 114.94 104.08 64.9 67.05 54.09 9.47
Ilośc akcji (mln) 2,300 2,250 2,212 2,158 2,109 2,030 1,932 1,876 1,857 1,850 1,820 1,793
Ważona ilośc akcji (mln) 2,300 2,250 2,212 2,161 2,112 2,032 1,934 1,878 1,858 1,851 1,825 1,800
Waluta JPY JPY JPY JPY JPY JPY JPY JPY JPY JPY JPY JPY